Built on Peer Reviewed Science

The technology underlying our instruments has been featured in a number of high impact, peer-reviewed journals.

Publication

Antibody Affinity Governs the Inhibition of SARS‑CoV‑2 Spike/ACE2 Binding in Patient Serum

read the paper

Publication

Our technology reveals the differences in the antibody affinity and stoichiometry for four clinical stage anti-Aβ drug candidates to treat Alzheimer’s Disease

read the abstract

Publication

Clinical researchers discover the spectrum of antibody affinity from plasma of COVID-patients using our technology

Read the abstract

Publication

Microfluidic diffusional sizing helps elucidate the specificity and selectivity of designed antibodies against Aβ oligomers

read the abstract

A full list of all the papers showing the research behind Fluidic Analytics and microfluidic diffusional sizing (MDS) can be found here. As well as seeing where others have used our products to make amazing discoveries

all publications

The Fluidity One platform enables quantification and characterization of any protein interaction –

even in complex backgrounds or with challenging targets

Find Out More